Schizophrenia--time to commit to policy change.

Care and outcomes for people with schizophrenia have improved in recent years, but further progress is needed to help more individuals achieve an independent and fulfilled life. This report sets out the current need, informs policy makers and all relevant stakeholders who influence care quality, and supports their commitment to creating a better future. The authors recommend the following policy actions, based on research evidence, stakeholder consultation, and examples of best practice worldwide. (1) Provide an evidence-based, integrated care package for people with schizophrenia that addresses their mental and physical health needs. (2) Provide support for people with schizophrenia to enter and to remain in their community, and develop mechanisms to help guide them through the complex benefit and employment systems. (3) Provide concrete support, information, and educational programs to families and carers on how to enhance care for an individual living with schizophrenia in a manner that entails minimal disruption to their lives. (4) All stakeholders, including organizations that support people living with schizophrenia, should be consulted to regularly revise, update, and improve policy on the management of schizophrenia. (5) Provide support, which is proportionate to the impact of the disease, for research and development of new treatments. (6) Establish adequately funded, ongoing, and regular awareness-raising campaigns that form an integral part of routine plans of action. Implementation of the above recommendations will require engagement by every stakeholder, but with commitment from all, change can be achieved.

[1]  M. Knapp,et al.  Early intervention for first‐episode psychosis: broadening the scope of economic estimates , 2016, Early intervention in psychiatry.

[2]  S. Saxena,et al.  Comprehensive mental health action plan 2013-2020. , 2015, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[3]  D. Streiner,et al.  RISK OF SYMPTOM RECURRENCE WITH MEDICATION DISCONTINUATION IN FIRST-EPISODE PSYCHOSIS: A SYSTEMATIC REVIEW , 2014, Schizophrenia Research.

[4]  M. Mimura,et al.  Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. , 2014, Schizophrenia bulletin.

[5]  J. Veijola,et al.  A systematic review and meta-analysis of recovery in schizophrenia. , 2013, Schizophrenia bulletin.

[6]  M. Dempster,et al.  Effectiveness of criminal justice liaison and diversion services for offenders with mental disorders: a review. , 2013, Psychiatric services.

[7]  M. Harrow,et al.  Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? , 2013, Schizophrenia bulletin.

[8]  M. Swartz,et al.  Costs of criminal justice involvement among persons with serious mental illness in connecticut. , 2013, Psychiatric services.

[9]  M. Parsonage,et al.  Peer support in mental health care: is it good value for money? , 2013 .

[10]  K. M. Dominguez Mental Disorders and Vulnerability to Homicidal Death: Swedish Nationwide Cohort Study , 2013 .

[11]  E. Norton,et al.  The impact of changes in psychiatric bed supply on jail use by persons with severe mental illness. , 2013, The journal of mental health policy and economics.

[12]  H. Goldman,et al.  Economic grand rounds: financing first-episode psychosis services in the United States. , 2013, Psychiatric services.

[13]  M. Mimura,et al.  The cost of schizophrenia in Japan , 2013, Neuropsychiatric disease and treatment.

[14]  N. Bargalló,et al.  Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and Functional Neuroimaging Study , 2013, Biological Psychiatry.

[15]  H. Steadman,et al.  Law & psychiatry: what can we say about mental health courts today? , 2013, Psychiatric services.

[16]  D. Penn,et al.  Psychosocial treatments for schizophrenia. , 2013, Annual review of clinical psychology.

[17]  Marilyn A Winkleby,et al.  Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. , 2013, The American journal of psychiatry.

[18]  P. Caputi,et al.  Development of a short measure of psychological recovery in serious mental illness: the STORI-30 , 2013, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.

[19]  R. Emsley,et al.  The nature of relapse in schizophrenia , 2013, BMC Psychiatry.

[20]  R. Drake,et al.  Supported employment: cost-effectiveness across six European sites. , 2013, World psychiatry : official journal of the World Psychiatric Association.

[21]  Norman Sartorius,et al.  Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey , 2013, The Lancet.

[22]  R. Stewart,et al.  Diagnostic Procedures, Revascularization, and Inpatient Mortality After Acute Myocardial Infarction in Patients With Schizophrenia and Bipolar Disorder , 2013, Psychosomatic medicine.

[23]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[24]  R. Murray,et al.  The Myth of Schizophrenia as a Progressive Brain Disease , 2012, Schizophrenia bulletin.

[25]  T. Taskila,et al.  Working with Schizophrenia: Pathways to Employment, Recovery & Inclusion , 2013 .

[26]  In English,et al.  The Numbers Count: Mental Disorders in America , 2013 .

[27]  A. Kleinman,et al.  Mental health and the global agenda. , 2013, The New England journal of medicine.

[28]  C. Vega,et al.  Convention on the Rights of Persons with Disabilities and Optional Protocol , 2013 .

[29]  Dana Alonzo,et al.  Social Support and Religion: Mental Health Service Use and Treatment of Schizophrenia , 2013, Community Mental Health Journal.

[30]  C. Glendinning,et al.  Personalisation through Individual Budgets: Does It Work and for Whom? , 2012 .

[31]  S. Miyamoto,et al.  Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents , 2012, Molecular Psychiatry.

[32]  Member States,et al.  Convention on the Rights of Persons with Disabilities and Optional Protocol , 2012 .

[33]  M. Knapp,et al.  Effective Interventions in schizophrenia: the economic case. , 2012 .

[34]  L. A. Pratt Characteristics of adults with serious mental illness in the United States household population in 2007. , 2012, Psychiatric services.

[35]  R. Drake,et al.  Mental Health Disability , 2012 .

[36]  P. Buckley,et al.  Peers and peer-led interventions for people with schizophrenia. , 2012, The Psychiatric clinics of North America.

[37]  Michael F. Green,et al.  Functional impairment in people with schizophrenia: Focus on employability and eligibility for disability compensation , 2012, Schizophrenia Research.

[38]  A. David,et al.  Associations of homelessness and residential mobility with length of stay after acute psychiatric admission , 2012, BMC Psychiatry.

[39]  J. Vázquez-Barquero,et al.  Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. , 2012, Journal of psychiatric research.

[40]  M. Knapp Mental health in an age of austerity , 2012, Evidence Based Mental Health.

[41]  Kristen M. Mackowick,et al.  Treatment of Tobacco Dependence in People With Mental Health and Addictive Disorders , 2012, Current Psychiatry Reports.

[42]  J. Cook,et al.  Results of a randomized controlled trial of mental illness self-management using Wellness Recovery Action Planning. , 2012, Schizophrenia bulletin.

[43]  H. Stuart,et al.  Paradigms Lost: Fighting Stigma and the Lessons Learned , 2012 .

[44]  L. Schopp,et al.  Relationships Among Spirituality, Religious Practices, Personality Factors, and Health for Five Different Faith Traditions , 2012, Journal of Religion and Health.

[45]  John M. Davis,et al.  Maintenance treatment with antipsychotic drugs for schizophrenia. , 2012, The Cochrane database of systematic reviews.

[46]  W. Greiner,et al.  The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective , 2012, Health Economics Review.

[47]  Lars Hansson,et al.  The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia , 2012, PloS one.

[48]  I. Cormac,et al.  Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. , 2012, The Cochrane database of systematic reviews.

[49]  D. Kelly,et al.  The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements , 2012 .

[50]  M. Lambert,et al.  Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial). , 2012, The Journal of clinical psychiatry.

[51]  Amy Johnson I should be included in the census. , 2012, Schizophrenia bulletin.

[52]  H. Ireys,et al.  Evidence-Based Treatment for Schizophrenia and Bipolar Disorder in State Medicaid Programs , 2012 .

[53]  M. Harrow,et al.  Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study , 2012, Psychological Medicine.

[54]  R. Drake,et al.  Generalizability of the Individual Placement and Support (IPS) model of supported employment outside the US , 2012, World psychiatry : official journal of the World Psychiatric Association.

[55]  G. Thornicroft,et al.  Anticipated discrimination among people with schizophrenia , 2012, Acta psychiatrica Scandinavica.

[56]  A. Douaihy,et al.  Treatment of substance abusing patients with comorbid psychiatric disorders. , 2012, Addictive behaviors.

[57]  G. Thornicroft Physical health disparities and mental illness: the scandal of premature mortality , 2011, British Journal of Psychiatry.

[58]  R. Drake,et al.  Why not implement supported employment? , 2011, Psychiatric services.

[59]  S. Rourke,et al.  Housing Status as an Independent Predictor of Functional Capacity in Patients With Schizophrenia , 2011, The Journal of nervous and mental disease.

[60]  J. Os,et al.  Cost of disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.

[61]  J. Aagaard,et al.  Clinical outcome of assertive community treatment (ACT) in a rural area in Denmark: A case–control study with a 2-year follow-up , 2011, Nordic journal of psychiatry.

[62]  T. Laursen Life expectancy among persons with schizophrenia or bipolar affective disorder , 2011, Schizophrenia Research.

[63]  J. Os,et al.  The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.

[64]  D. Vancampfort,et al.  Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices , 2011, Psychological Medicine.

[65]  L. Schmidt,et al.  The impact of substance use disorders on the course of schizophrenia—A 15-year follow-up study Dual diagnosis over 15 years , 2011, Schizophrenia Research.

[66]  D. Goff,et al.  The treatment of cognitive impairment in schizophrenia , 2011, Pharmacology Biochemistry and Behavior.

[67]  E. Susser,et al.  A Randomized Trial of Critical Time Intervention to Prevent Homelessness in Persons with Severe Mental Illness following Institutional Discharge , 2011 .

[68]  P. Gorroochurn,et al.  Randomized trial of critical time intervention to prevent homelessness after hospital discharge. , 2011, Psychiatric services.

[69]  K. Morley,et al.  Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. , 2011, Archives of general psychiatry.

[70]  R. Kahn,et al.  Sexual Dysfunction in First-Episode Schizophrenia Patients: Results From European First Episode Schizophrenia Trial , 2011, Journal of clinical psychopharmacology.

[71]  A. Mitchell,et al.  Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis , 2011, British Journal of Psychiatry.

[72]  L. Dixon,et al.  Outcomes of a randomized study of a peer-taught Family-to-Family Education Program for mental illness. , 2011, Psychiatric services.

[73]  Andrea C. Fernandes,et al.  Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London , 2011, PloS one.

[74]  Vyv Huddy,et al.  A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes , 2012 .

[75]  I. Cormac,et al.  WITHDRAWN: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. , 2011, The Cochrane database of systematic reviews.

[76]  P. Delespaul,et al.  Assertive Community Treatment in the Netherlands: Outcome and Model Fidelity , 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[77]  A. Fernandez-liria,et al.  Effectiveness of Continuity-of-Care Programs to reduce time in hospital in persons with schizophrenia , 2011, Epidemiology and Psychiatric Sciences.

[78]  T. Barnes Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.

[79]  H. Möller,et al.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care , 2011, World psychiatry : official journal of the World Psychiatric Association.

[80]  N. Breitborde,et al.  Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial , 2011, BMC psychiatry.

[81]  Stefan Priebe,et al.  Does the Therapeutic Relationship Predict Outcomes of Psychiatric Treatment in Patients with Psychosis? A Systematic Review , 2010, Psychotherapy and Psychosomatics.

[82]  J. Mari,et al.  Family intervention for schizophrenia. , 2010, The Cochrane database of systematic reviews.

[83]  D. Naber,et al.  Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone , 2010, European Neuropsychopharmacology.

[84]  R. Perkins,et al.  The Individual Placement and Support approach to vocational rehabilitation for young people with first episode psychosis in the UK , 2010, Journal of mental health.

[85]  John M. Davis,et al.  Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis , 2010, Schizophrenia Research.

[86]  Mark Taylor,et al.  Suicide and schizophrenia: a systematic review of rates and risk factors , 2010, Journal of psychopharmacology.

[87]  H. Goldman Will health insurance reform in the United States help people with schizophrenia? , 2010, Schizophrenia bulletin.

[88]  Keith A Puffer The intruder of the mind. , 2010, Schizophrenia bulletin.

[89]  H. Lublin,et al.  Psychiatrists’ attitude towards and knowledge of clozapine treatment , 2010, Journal of psychopharmacology.

[90]  S. Gilbody,et al.  Smoking cessation in severe mental illness: what works? , 2010, Addiction.

[91]  B. Everitt,et al.  Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis , 2010, Schizophrenia Research.

[92]  M. Keshavan,et al.  Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. , 2010, Archives of general psychiatry.

[93]  S. Watanabe-Galloway,et al.  Toward successful postbooking diversion: what are the next steps? , 2010, Psychiatric services.

[94]  P. McGuire,et al.  Effect of early intervention on 5-year outcome in non-affective psychosis , 2010, British Journal of Psychiatry.

[95]  C. Lloyd,et al.  Subjective and Objective Indicators of Recovery in Severe Mental Illness: a Cross-Sectional Study , 2010, The International journal of social psychiatry.

[96]  A. Mortimer,et al.  Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. , 2010, Clinical schizophrenia & related psychoses.

[97]  H. Ascher-Svanum,et al.  Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia , 2010, BMC psychiatry.

[98]  Nuno Lunet,et al.  Burden of Disease and Risk Factors , 2010 .

[99]  G. Remington,et al.  Progress in Defining Optimal Treatment Outcome in Schizophrenia , 2010, CNS drugs.

[100]  F. Dickerson,et al.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. , 2010, Schizophrenia bulletin.

[101]  P. Weiden,et al.  The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. , 2009, The Journal of clinical psychiatry.

[102]  Paolo Scotti Recovery as discovery. , 2009, Schizophrenia bulletin.

[103]  R. Warner Recovery from schizophrenia and the recovery model , 2009, Current opinion in psychiatry.

[104]  R. Kahn,et al.  Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). , 2009, The American journal of psychiatry.

[105]  S. Marder,et al.  Psychosocial treatments to promote functional recovery in schizophrenia. , 2009, Schizophrenia bulletin.

[106]  John M Davis,et al.  A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. , 2009, The American journal of psychiatry.

[107]  Norman Sartorius,et al.  Global Pattern of Experienced and Anticipated Discrimination against People with Schizophrenia: a Cross-sectional Survey , 2009 .

[108]  John M. Davis,et al.  Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis , 2009, The Lancet.

[109]  D. Medoff,et al.  Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. , 2009, General hospital psychiatry.

[110]  R. Liberman,et al.  Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia. , 2009, Schizophrenia bulletin.

[111]  M. Lambert,et al.  Rates and predictors of remission and recovery during 3 years in 392 never‐treated patients with schizophrenia , 2008, Acta psychiatrica Scandinavica.

[112]  S. Hutton,et al.  Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia , 2008, The British journal of psychiatry : the journal of mental science.

[113]  P. Lelliott,et al.  Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme , 2008, Acta psychiatrica Scandinavica.

[114]  Richard A. Van Dorn,et al.  Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia , 2008, British Journal of Psychiatry.

[115]  K. Mueser,et al.  A meta-analysis of controlled research on social skills training for schizophrenia. , 2008, Journal of consulting and clinical psychology.

[116]  J. Lieberman,et al.  Science and recovery in schizophrenia. , 2008, Psychiatric services.

[117]  Martin Knapp,et al.  Paying the price: the cost of mental health care in England to 2026 , 2008 .

[118]  G. Morken,et al.  Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia , 2008, BMC psychiatry.

[119]  L. Hranov,et al.  Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial , 2008, The Lancet.

[120]  Werner Kissling,et al.  Peer-counseling in schizophrenia: patients consult patients. , 2008, Patient education and counseling.

[121]  M. Ferriter,et al.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia. , 2007, Schizophrenia bulletin.

[122]  B. Everitt,et al.  Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor , 2007, Schizophrenia bulletin.

[123]  J. O. Johannessen,et al.  The key to reducing duration of untreated first psychosis: information campaigns. , 2007, Schizophrenia bulletin.

[124]  Mike Brady Beating the odds--nothing is impossible, its just a road less traveled. , 2007, Schizophrenia bulletin.

[125]  Nancy Vuckovic,et al.  Understanding how clinician-patient relationships and relational continuity of care affect recovery from serious mental illness: STARS study results. , 2008, Psychiatric rehabilitation journal.

[126]  R. Drake,et al.  Individual placement and support for individuals with recent-onset schizophrenia: integrating supported education and supported employment. , 2008, Psychiatric rehabilitation journal.

[127]  P. Weiden Understanding and addressing adherence issues in schizophrenia: from theory to practice. , 2007, The Journal of clinical psychiatry.

[128]  N. Tarrier,et al.  Needs‐based cognitive‐behavioural family intervention for patients suffering from schizophrenia: 5‐year follow‐up of a randomized controlled effectiveness trial , 2007, Acta psychiatrica Scandinavica.

[129]  E. Twamley,et al.  A meta-analysis of cognitive remediation in schizophrenia. , 2007, The American journal of psychiatry.

[130]  H. Verdoux,et al.  Time between schizophrenia onset and first request for disability status in France and associated patient characteristics. , 2007, Psychiatric services.

[131]  M. Maj,et al.  Physical illness and schizophrenia: a review of the literature , 2007, Acta psychiatrica Scandinavica.

[132]  R. Drake,et al.  The effectiveness of supported employment for people with severe mental illness: a randomised controlled trial , 2007, The Lancet.

[133]  R. Warner Recovery From Schizophrenia: An International Perspective. A Report From the WHO Collaborative Project, the International Study of Schizophrenia , 2007 .

[134]  S. Harvey,et al.  Outcomes of public concern in schizophrenia , 2007, British Journal of Psychiatry.

[135]  T. Aubry,et al.  A review of the literature on the effectiveness of housing and support, assertive community treatment, and intensive case management interventions for persons with mental illness who have been homeless. , 2007, The American journal of orthopsychiatry.

[136]  R. Rosenheck,et al.  Outcomes of critical time intervention case management of homeless veterans after psychiatric hospitalization. , 2007, Psychiatric services.

[137]  J. Newcomer,et al.  Monitoring and managing weight gain in the mentally ill. , 2007, The Journal of clinical psychiatry.

[138]  P. Weiden,et al.  Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications. , 2007, The Journal of clinical psychiatry.

[139]  Sarah Wild,et al.  Improving access to psychological therapies , 2007 .

[140]  P. Lysaker,et al.  Therapeutic Alliance and Improvements in Work Performance Over Time in Patients With Schizophrenia , 2007, The Journal of nervous and mental disease.

[141]  C. Coldwell,et al.  The effectiveness of assertive community treatment for homeless populations with severe mental illness: a meta-analysis. , 2007, The American journal of psychiatry.

[142]  M. Sajatovic,et al.  Is antipsychotic medication stigmatizing for people with mental illness? , 2007, International review of psychiatry.

[143]  M. Maj,et al.  Physical Illness and Schizophrenia: Method , 2007 .

[144]  K. Gill,et al.  The concept of "being in recovery". , 2007, Psychiatric rehabilitation journal.

[145]  Kim Hoppera,et al.  Rethinking social recovery in schizophrenia : What a capabilities approach might offer , 2007 .

[146]  M. Falagas,et al.  A Comparative Study on the Cost of New Antibiotics and Drugs of Other Therapeutic Categories , 2006, PloS one.

[147]  C. Lauber Social inclusion of people with mental illness. , 2006 .

[148]  M. Pfammatter,et al.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. , 2006, Schizophrenia bulletin.

[149]  Peter B. Jones,et al.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.

[150]  K. Kotrla,et al.  Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders. , 2006, Psychiatric services.

[151]  S. Marder Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness. , 2006, The Journal of clinical psychiatry.

[152]  S. Leucht,et al.  Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. , 2006, The Journal of clinical psychiatry.

[153]  R. Murray,et al.  Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. , 2006, Health technology assessment.

[154]  K. Snyder Kurt Snyder's personal experience with schizophrenia. , 2006, Schizophrenia bulletin.

[155]  M. Swartz,et al.  Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. , 2006, The Journal of clinical psychiatry.

[156]  Marvin Swartz,et al.  Barriers to employment for people with schizophrenia. , 2006, The American journal of psychiatry.

[157]  J. Bobes,et al.  Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence , 2006, European Psychiatry.

[158]  Peter B. Jones,et al.  Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. , 2005, Schizophrenia bulletin.

[159]  A. Bellack Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. , 2005, Schizophrenia bulletin.

[160]  M. Ruggeri,et al.  Does Additional Care Provided by a Consumer Self-Help Group Improve Psychiatric Outcome? A Study in an Italian Community-based Psychiatric Service , 2005, Community Mental Health Journal.

[161]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[162]  R. Kessler,et al.  The economic burden of schizophrenia in the United States in 2002. , 2005, The Journal of clinical psychiatry.

[163]  G. Krarup,et al.  A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness , 2005, BMJ : British Medical Journal.

[164]  T. Brugha,et al.  The European Schizophrenia Cohort , 2005, Social Psychiatry and Psychiatric Epidemiology.

[165]  M. Hummer,et al.  Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects , 2005, European Psychiatry.

[166]  P. Tyrer,et al.  Nidotherapy: making the environment do the therapeutic work , 2005 .

[167]  A. Riecher-Rössler,et al.  First onset and early symptomatology of schizophrenia , 1992, European Archives of Psychiatry and Clinical Neuroscience.

[168]  A. Medalia,et al.  What predicts a good response to cognitive remediation interventions? , 2005, Schizophrenia bulletin.

[169]  Mondher Toumi,et al.  The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. , 2005, Social psychiatry and psychiatric epidemiology.

[170]  L. Grossman,et al.  Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study. , 2005, Schizophrenia bulletin.

[171]  R. Murray,et al.  The environment and schizophrenia: the role of cannabis use. , 2005, Schizophrenia bulletin.

[172]  G. Dunn,et al.  The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis , 2004, BMJ : British Medical Journal.

[173]  Bonnie L Rickelman,et al.  ANOSOGNOSIA IN INDIVIDUALS WITH SCHIZOPHRENIA: TOWARD RECOVERY OF INSIGHT , 2004, Issues in mental health nursing.

[174]  R. Warner Recovery from schizophrenia , 2004 .

[175]  R. McCreadie,et al.  Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. , 2003, The British journal of psychiatry : the journal of mental science.

[176]  B. Ivarsson,et al.  Integrated care in schizophrenia: a 2‐year randomized controlled study of two community‐based treatment programs , 2003, Acta psychiatrica Scandinavica.

[177]  R. Drake,et al.  Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA , 2003, British Journal of Psychiatry.

[178]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[179]  C. Holman,et al.  Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. , 2003, The British journal of psychiatry : the journal of mental science.

[180]  David Taylor,et al.  Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. , 2003, The Journal of clinical psychiatry.

[181]  Alan I Green,et al.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). , 2003, Archives of general psychiatry.

[182]  A. House,et al.  Involving users in the delivery and evaluation of mental health services: systematic review , 2002, BMJ : British Medical Journal.

[183]  W. McFarlane Multifamily Groups in the Treatment of Severe Psychiatric Disorders , 2002 .

[184]  R. Chilvers,et al.  Supported housing for people with severe mental disorders. , 2002, The Cochrane database of systematic reviews.

[185]  S. Leucht,et al.  The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis. , 2004, Schizophrenia bulletin.

[186]  N. Tarrier,et al.  Needs‐based cognitive‐behavioural family intervention for carers of patients suffering from schizophrenia: 12‐month follow‐up , 2001, Acta psychiatrica Scandinavica.

[187]  E. Laska,et al.  Recovery from psychotic illness: A 15- and 25-year international follow-up study , 2001, British Journal of Psychiatry.

[188]  J. Lieberman,et al.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. , 2001, The American journal of psychiatry.

[189]  R. McCreadie,et al.  Cigarette smoking and schizophrenia , 2000 .

[190]  P. Sparén,et al.  Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study , 2000, BMJ : British Medical Journal.

[191]  D. Braff,et al.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.

[192]  E. Latimer Economic Impacts of Assertive Community Treatment: A Review of the Literature , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[193]  G. Andrews,et al.  Burden of disease , 1998, British Journal of Psychiatry.

[194]  R. Rosenheck,et al.  Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1998, Archives of general psychiatry.

[195]  R. Drake,et al.  Models of community care for severe mental illness: a review of research on case management. , 1998, Schizophrenia bulletin.

[196]  R Giel,et al.  Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. , 1998, Schizophrenia bulletin.

[197]  N. Sartorius Fighting schizophrenia and its stigma , 1997, British Journal of Psychiatry.

[198]  M. Moller,et al.  The Three R's Rehabilitation Program: A prevention approach for the management of relapse symptoms associated with psychiatric diagnoses. , 1997 .

[199]  R. Kessler,et al.  Patterns and correlates of self-help group membership in the United States , 1997 .

[200]  M. Goldstein Psycho-education and family treatment related to the phase of a psychotic disorder , 1996, International clinical psychopharmacology.

[201]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[202]  R. Dushay,et al.  Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. , 1995, Family process.

[203]  R. Dushay,et al.  Multiple-family groups and psychoeducation in the treatment of schizophrenia. , 1995, New directions for mental health services.

[204]  M. Tohen,et al.  One hundred years of schizophrenia: a meta-analysis of the outcome literature. , 1994 .

[205]  C. Waternaux,et al.  One hundred years of schizophrenia: A meta-analysis of the outcome literature , 1993, Schizophrenia Research.

[206]  J. Lieberman,et al.  Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.

[207]  J. Leff,et al.  A Trial of Family Therapy versus a Relatives' Group for Schizophrenia , 1990, British Journal of Psychiatry.

[208]  M. Shepherd Non-Specific Aspects of Treatment , 1989 .

[209]  J. Leff,et al.  A Trial of Family Therapy v. a Relatives Group for Schizophrenia , 1989, British Journal of Psychiatry.

[210]  J. Strauss,et al.  The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. , 1987, The American journal of psychiatry.

[211]  J. Davis,et al.  Maintenance therapy and the natural course of schizophrenia. , 1985, The Journal of clinical psychiatry.

[212]  Phil Hodkins A time of change , 1983 .

[213]  G. Hogarty,et al.  Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.